Carvedilol Tablet, Film Coated
Product Images NDC 71335-1937

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 71335-1937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph showing percentage mortality over 21 months comparing Carvedilol and placebo groups. The x-axis represents months, and the y-axis represents percent mortality. The Carvedilol group shows consistently lower mortality than the placebo group. A p-value of 0.0014 is indicated, suggesting statistical comparison between groups.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot chart showing hazard ratios with confidence intervals for various patient subgroups including sex (men, women), age groups (<65, ≥65), race (non-black, black), diabetic status, ischemic vs nonischemic, heart rate categories, systolic blood pressure levels, spironolactone use, and all patients. The horizontal axis represents the hazard ratio ranging from 0.0 to 2.0, with a vertical reference line at 1.0.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A survival analysis Kaplan-Meier curve comparing mortality rates over 24 months between Carvedilol and placebo groups in the CAPRICORN study. The y-axis represents % mortality, and the x-axis represents time in months. The Carvedilol group shows lower mortality than placebo, with a reported P value of 0.03.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' showing two forest plots. The plots depict hazard ratios for various patient subgroups based on age, gender, timing post-myocardial infarction, prior treatments, clinical classifications, presence of thrombolytic therapy, and cardiovascular risk factors. Each subgroup is represented by a point estimate with confidence intervals across a hazard ratio scale from 0.4 to 1.3.*
FDA Label Image

Label (Lbl713351937)

Label (Lbl713351937)
Carvedilol 6.25 mg tablet film coated packaging label from Bryant Ranch Prepack. The label indicates it is a white round tablet, compares to Coreg 6.25 mg tablets by Glenmark Pharmaceuticals Ltd., and includes storage instructions to keep in a light-resistant container and store at 20°-25°C. The label also shows the NDC 71335-1937 and a barcode.*
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)
Chemical structure of Carvedilol, illustrating the molecular arrangement including aromatic rings, hydroxyl, ether, and amine groups characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.